2014 Q1 Form 10-Q Financial Statement

#000110465914007141 Filed on February 06, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2013 Q1
Revenue $7.019M $7.401M $6.897M
YoY Change 1.77% 2.2% 15.22%
Cost Of Revenue $4.553M $4.245M $4.140M
YoY Change 9.98% -3.02% 5.34%
Gross Profit $2.466M $3.156M $2.707M
YoY Change -8.9% 10.16% 31.86%
Gross Profit Margin 35.13% 42.64% 39.25%
Selling, General & Admin $3.190M $2.696M $2.030M
YoY Change 57.14% 23.73% 21.56%
% of Gross Profit 129.36% 85.42% 74.99%
Research & Development $80.00K $108.0K $80.00K
YoY Change 0.0% 107.69% 0.0%
% of Gross Profit 3.24% 3.42% 2.96%
Depreciation & Amortization $310.0K $290.0K $230.0K
YoY Change 34.78% 31.82% 21.05%
% of Gross Profit 12.57% 9.19% 8.5%
Operating Expenses $3.270M $2.823M $2.100M
YoY Change 55.71% 26.48% 19.32%
Operating Profit -$797.0K $332.0K $607.0K
YoY Change -231.3% -47.55% 107.17%
Interest Expense -$30.00K -$29.00K -$20.00K
YoY Change 50.0% 107.14% 0.0%
% of Operating Profit -8.73% -3.29%
Other Income/Expense, Net -$29.00K
YoY Change 107.14%
Pretax Income -$1.090M $293.0K $510.0K
YoY Change -313.73% -52.67% 70.0%
Income Tax -$500.0K $257.0K -$2.080M
% Of Pretax Income 87.71% -407.84%
Net Earnings -$590.0K $40.00K $2.590M
YoY Change -122.78% -93.44% 123.28%
Net Earnings / Revenue -8.41% 0.54% 37.55%
Basic Earnings Per Share -$0.09 $0.02 $0.48
Diluted Earnings Per Share -$0.09 $0.02 $0.47
COMMON SHARES
Basic Shares Outstanding 5.486M shares 5.486M 5.464M shares
Diluted Shares Outstanding 5.659M

Balance Sheet

Concept 2014 Q1 2013 Q4 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.310M $2.510M $4.360M
YoY Change -1.15% -30.47% -13.83%
Cash & Equivalents $4.312M $2.510M $4.364M
Short-Term Investments
Other Short-Term Assets $560.0K $540.0K $370.0K
YoY Change 51.35% 28.57% -15.91%
Inventory $5.341M $5.230M $3.688M
Prepaid Expenses
Receivables $2.376M $4.502M $3.766M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.58M $12.78M $12.19M
YoY Change 3.22% 8.7% 6.76%
LONG-TERM ASSETS
Property, Plant & Equipment $14.75M $11.37M $11.83M
YoY Change 24.76% 34.18% 102.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $902.0K $843.0K $772.0K
YoY Change 16.84% 9.62% 61.51%
Total Long-Term Assets $17.39M $17.09M $16.40M
YoY Change 6.08% 57.87% 115.2%
TOTAL ASSETS
Total Short-Term Assets $12.58M $12.78M $12.19M
Total Long-Term Assets $17.39M $17.09M $16.40M
Total Assets $29.98M $29.87M $28.59M
YoY Change 4.86% 32.28% 50.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.147M $2.437M $1.852M
YoY Change 69.92% 24.59% 7.3%
Accrued Expenses $774.0K $831.0K $872.0K
YoY Change -11.24% 4.79% -35.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $202.0K $128.0K
YoY Change 56.25% 236.67% -45.3%
Total Short-Term Liabilities $4.155M $3.530M $2.885M
YoY Change 44.02% 23.64% -14.16%
LONG-TERM LIABILITIES
Long-Term Debt $5.260M $5.303M $5.454M
YoY Change -3.56% 131.98% 1263.5%
Other Long-Term Liabilities $10.00K $20.00K $20.00K
YoY Change -50.0% 0.0% 100.0%
Total Long-Term Liabilities $5.270M $5.303M $5.454M
YoY Change -3.37% 131.98% 1263.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.155M $3.530M $2.885M
Total Long-Term Liabilities $5.270M $5.303M $5.454M
Total Liabilities $9.426M $8.851M $8.360M
YoY Change 12.75% 71.63% 121.57%
SHAREHOLDERS EQUITY
Retained Earnings -$9.450M -$8.787M -$9.030M
YoY Change 4.65% -24.2% -31.56%
Common Stock $110.0K $29.81M $29.19M
YoY Change -99.62% 2.72% 2.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.55M $21.02M $20.16M
YoY Change
Total Liabilities & Shareholders Equity $29.98M $29.87M $28.59M
YoY Change 4.86% 32.28% 50.16%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2013 Q1
OPERATING ACTIVITIES
Net Income -$590.0K $40.00K $2.590M
YoY Change -122.78% -93.44% 123.28%
Depreciation, Depletion And Amortization $310.0K $290.0K $230.0K
YoY Change 34.78% 31.82% 21.05%
Cash From Operating Activities $2.110M -$130.0K $1.210M
YoY Change 74.38% -425.0% -19.33%
INVESTING ACTIVITIES
Capital Expenditures -$760.0K -$750.0K -$600.0K
YoY Change 26.67% -62.31% 1.69%
Acquisitions
YoY Change
Other Investing Activities $480.0K $160.0K -$3.080M
YoY Change -115.58% -91.88%
Cash From Investing Activities -$280.0K -$590.0K -$3.680M
YoY Change -92.39% 2850.0% 523.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.00K -40.00K 3.230M
YoY Change -101.24% 100.0% -8175.0%
NET CHANGE
Cash From Operating Activities 2.110M -130.0K 1.210M
Cash From Investing Activities -280.0K -590.0K -3.680M
Cash From Financing Activities -40.00K -40.00K 3.230M
Net Change In Cash 1.790M -760.0K 760.0K
YoY Change 135.53% 696357364258133900.0% -12.64%
FREE CASH FLOW
Cash From Operating Activities $2.110M -$130.0K $1.210M
Capital Expenditures -$760.0K -$750.0K -$600.0K
Free Cash Flow $2.870M $620.0K $1.810M
YoY Change 58.56% -69.46% -13.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
915000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
303000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3812000 USD
CY2013Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
200000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
5230000 USD
CY2013Q1 cyan Property Plant And Equipment Gross Before Non Depreciable Items
PropertyPlantAndEquipmentGrossBeforeNonDepreciableItems
15976000 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8835000 USD
CY2013Q4 cyan Property Plant And Equipment Gross Before Non Depreciable Items
PropertyPlantAndEquipmentGrossBeforeNonDepreciableItems
18570000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11122000 USD
CY2013Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3918000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11366000 USD
CY2013Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-19000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-45000 USD
CY2012Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-36000 USD
CY2013Q4 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
50000 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
148000 USD
CY2012Q4 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 USD
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0 USD
CY2013Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
501000 USD
CY2013Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
93000 USD
CY2013Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
72000 USD
CY2013Q1 us-gaap Accrued Rent Current
AccruedRentCurrent
21000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
165000 USD
CY2013Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
119000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
831000 USD
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
872000 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
5505000 USD
CY2013Q1 us-gaap Long Term Debt
LongTermDebt
5582000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
202000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5303000 USD
CY2013Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5454000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
202000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
205000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
199000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
203000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
214000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
4482000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Next Rolling Twelve Months
OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths
482000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo
442000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
341000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Four
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour
305000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive
299000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling After Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive
5087000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
6956000 USD
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
257000 USD
CY2012Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
592000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.775 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.021 pure
CY2013Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.877 pure
CY2012Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.020 pure
CY2013Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
cyan Income Taxes State Jurisdictions Number
IncomeTaxesStateJurisdictionsNumber
2 item
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36000 USD
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
36000 USD
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5486000 shares
CY2013Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
173000 shares
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5659000 shares
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2013Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
680142 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
172000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
172000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5475000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
181000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5656000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
725142 shares
CY2012Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
607000 USD
CY2012Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5464000 shares
CY2012Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
153000 shares
CY2012Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5617000 shares
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2012Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
732032 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1576000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5451000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1576000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
241000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5692000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
cyan Earnings Per Share Effect Of Dilutive Securities
EarningsPerShareEffectOfDilutiveSecurities
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
198000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2275000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
540851 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1474106 shares
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1474106 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
4.04
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
507040 shares
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
3.48
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-INDENT: -0.5in; MARGIN: 0in 0in 0pt 0.5in;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">1.</font></b><b><font style="FONT-SIZE: 3pt; FONT-WEIGHT: bold;" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></b> <b><font style="FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">BASIS OF PRESENTATION</font></b></p> <p style="TEXT-INDENT: -0.5in; MARGIN: 0in 0in 0pt 0.5in;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information pursuant to the instructions to Form&#160;10-Q and Regulation S-X of the Securities and Exchange Commission (SEC).&#160; These interim condensed consolidated financial statements are unaudited and, in the opinion of management, include all adjustments (consisting of normal recurring adjustments and accruals) necessary to present fairly the Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, and Condensed Consolidated Statements of Cash Flows for the periods presented in accordance with GAAP. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The Condensed Consolidated Balance Sheet as of March&#160;31, 2013 was derived from the audited financial statements. These condensed consolidated financial statements and notes should be read in conjunction with the Company&#8217;s consolidated financial statements for the year ended March&#160;31, 2013, contained in the Company&#8217;s annual report on Form&#160;10-K as filed with the SEC on June&#160;24, 2013.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The accompanying consolidated condensed financial statements include the accounts of Cyanotech Corporation and its wholly owned subsidiary, Nutrex Hawaii,&#160;Inc. (&#8220;Nutrex Hawaii&#8221; or &#8220;Nutrex&#8221;, collectively the &#8220;Company&#8221;). All significant intercompany balances and transactions have been eliminated in consolidation.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported.&#160; Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary.&#160; Actual results could differ from those estimates and assumptions.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Recent Accounting Pronouncements</font></i></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">In July&#160;2013, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued an Accounting Standards Update No.&#160;2013-11 on the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or tax credit carryforward, exists.&#160; Under the guidance, an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward.&#160; To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets.&#160; The assessment of whether a deferred tax asset is available is based on the unrecognized tax benefit and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date.&#160; The updated guidance is effective for fiscal years and interim periods within those years, beginning after December&#160;15, 2013.&#160; The adoption of this guidance is not expected to have a material effect on the Company&#8217;s Consolidated Financial Statements.</font></p> </div>
dei Entity Registrant Name
EntityRegistrantName
CYANOTECH CORP
dei Entity Central Index Key
EntityCentralIndexKey
0000768408
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5486438 shares
CY2013Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
21000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
8851000 USD
CY2013Q1 us-gaap Liabilities
Liabilities
8360000 USD
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
110000 USD
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
109000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29698000 USD
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29077000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8787000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
202000 USD
CY2013Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
128000 USD
CY2013Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
60000 USD
CY2013Q1 us-gaap Customer Deposits Current
CustomerDepositsCurrent
33000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2437000 USD
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1852000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3530000 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2885000 USD
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
18000 USD
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
110000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
426000 USD
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
263000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
12778000 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
12191000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1851000 USD
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3360000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3034000 USD
CY2013Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
3429000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
843000 USD
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
772000 USD
CY2013Q4 us-gaap Assets
Assets
29872000 USD
CY2013Q1 us-gaap Assets
Assets
28587000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2510000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4364000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4502000 USD
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3766000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
110000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8959000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
21021000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
20227000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29872000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28587000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5486438 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5463938 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5486438 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5463938 shares
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
7438000 USD
CY2012Q4 us-gaap Sales Revenue Net
SalesRevenueNet
7242000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
21646000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
20684000 USD
CY2013Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4293000 USD
CY2012Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4377000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
12656000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
12433000 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
3145000 USD
CY2012Q4 us-gaap Gross Profit
GrossProfit
2865000 USD
us-gaap Gross Profit
GrossProfit
8990000 USD
us-gaap Gross Profit
GrossProfit
8251000 USD
CY2013Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1685000 USD
CY2012Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1175000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4502000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3608000 USD
CY2013Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1011000 USD
CY2012Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1004000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3195000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2722000 USD
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
108000 USD
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
394000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
183000 USD
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
2823000 USD
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
2232000 USD
us-gaap Operating Expenses
OperatingExpenses
8136000 USD
us-gaap Operating Expenses
OperatingExpenses
6549000 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
322000 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
633000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
854000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1702000 USD
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-51000 USD
CY2013Q4 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-29000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-90000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-43000 USD
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-29000 USD
CY2012Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-90000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-94000 USD
CY2013Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
293000 USD
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
619000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
764000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1608000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-51000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
784000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
619000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
32000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
84000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
589000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
563000 USD
us-gaap Inventory Write Down
InventoryWriteDown
-10000 USD
cyan Provision For Inventory Reserve
ProvisionForInventoryReserve
-3000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
395000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
736000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1859000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1539000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-60000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
266000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
95000 USD
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
27000 USD
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-7000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
585000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
230000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-41000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-559000 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-3000 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
4000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
42000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
692000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-1509000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
281000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3362000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3292000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1853000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3573000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2281000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
78000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
616000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
259000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
35000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-43000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1429000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-1854000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-1452000 USD
us-gaap Interest Paid
InterestPaid
229000 USD
us-gaap Interest Paid
InterestPaid
98000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
118000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
57000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3609000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5061000 USD
us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
Prime rate
cyan Number Of Liability Classified Awards
NumberOfLiabilityClassifiedAwards
0 item
CY2013Q4 cyan Number Of Shareholder Approved Share Based Compensation Plans
NumberOfShareholderApprovedShareBasedCompensationPlans
2 item
CY2013Q4 cyan Noninventoriable Fixed Costs
NoninventoriableFixedCosts
44000 USD

Files In Submission

Name View Source Status
0001104659-14-007141-index-headers.html Edgar Link pending
0001104659-14-007141-index.html Edgar Link pending
0001104659-14-007141.txt Edgar Link pending
0001104659-14-007141-xbrl.zip Edgar Link pending
a13-26848_110q.htm Edgar Link pending
a13-26848_1ex31d1.htm Edgar Link pending
a13-26848_1ex31d2.htm Edgar Link pending
a13-26848_1ex32.htm Edgar Link pending
cyan-20131231.xml Edgar Link completed
cyan-20131231.xsd Edgar Link pending
cyan-20131231_cal.xml Edgar Link unprocessable
cyan-20131231_def.xml Edgar Link unprocessable
cyan-20131231_lab.xml Edgar Link unprocessable
cyan-20131231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending